This bill prohibits the use of federal funds for any military action against Venezuela from its enactment date through December 31, 2026, unless Congress either declares war or passes new specific authorization meeting War Powers Resolution standards. It directly affects all federal agencies and military operations that would require funding for actions targeting Venezuela. The key mechanism blocks funding for military force unless Congress explicitly authorizes it through one of two specific pathways. A narrow exception allows actions already compliant with existing War Powers Resolution rules. This is a funding restriction, not a ban on military action itself.
HR 4611 (EACH Act of 2025) requires all federally funded health programs - including Medicaid, Medicare, military health plans, and the Indian Health Service - to cover abortion services without restrictions, repealing the Hyde Amendment's long-standing ban on federal funding for most abortions. This directly affects millions of people enrolled in these programs, particularly low-income women, women of color (including 25% of Black women and 22% of Hispanic women on Medicaid), and young people. The bill mandates coverage in all federally administered health plans and prohibits state or private insurers from restricting abortion coverage in health insurance. It aims to eliminate current federal and state barriers that deny abortion access to people who rely on government health programs.
SJRES 82 is a joint resolution seeking to block a rule issued by the Department of Health and Human Services (HHS) regarding how the agency should follow the text of the Administrative Procedure Act (APA), a federal law governing how agencies create regulations. The rule, published in March 2025, was identified by the Government Accountability Office as a "rule" subject to the Congressional Review Act. If enacted, this resolution would void the HHS policy, preventing it from taking effect and requiring HHS to disregard this specific internal guideline. The bill directly affects HHS's rulemaking procedures by invalidating the policy statement on APA adherence.
The Closing the Contraception Coverage Gap Act requires Medicare Part B, Part C, and Part D to cover all FDA-approved contraceptive items and services at no cost-sharing starting January 1, 2027. This includes not just contraceptive methods themselves but also related clinical services like counseling, examinations, device insertion, and follow-up care. The bill ensures dual-eligible Medicare and Medicaid beneficiaries receive contraceptive coverage that matches Medicaid's comprehensiveness. It also mandates two studies on contraceptive coverage gaps, with reports to Congress within 1-2 years.
The Data Care Act of 2025 requires online service providers (like social media platforms or apps that collect user data) to securely handle "individual identifying data," especially sensitive information like health details, biometrics, financial data, or precise location. It imposes three key duties: (1) reasonably securing data from breaches, (2) not misusing data to harm users or benefit themselves, and (3) restricting data sharing to third parties only with strict confidentiality contracts. The Federal Trade Commission and state attorneys general can enforce these rules through penalties for violations, with civil fines calculated based on the number of affected users or days of noncompliance. The law directly affects major digital platforms collecting user data and takes effect 180 days after enactment.
The NIH Clinical Trial Integrity Act requires NIH-funded research organizations conducting clinical trials (for drugs, devices, biological products, or behavioral interventions) to set specific, measurable diversity goals for participant recruitment and retention, focusing on race, ethnicity, age, and sex to reflect affected populations or the general U.S. population where appropriate. It mandates annual reporting of demographic data and retention rates by these groups, researcher training on diversity, and detailed plans for analyzing results across these categories. The bill also includes a study to modernize regulations on reimbursing participants' out-of-pocket costs and compensation, plus a national awareness campaign and grants to community organizations to improve outreach to underrepresented groups. This directly affects NIH-funded trial sponsors and aims to make clinical research more representative.
# Summary of Proposed Tax Code Amendment
This document is a comprehensive proposal for tax code amendments, primarily focused on extending, modifying, and creating new tax credits related to clean energy, energy efficiency, and environmental initiatives. The key components include:
## Housing and Residential Credits
- **First-Time Homebuyer Tax Credit**: A refundable credit for first-time homebuyers (Section 13001)
- **Renter Tax Credit**: A refundable credit for renters paying more than 30% of their adjusted gross income in rent (Section 13002)
## Clean Energy Credits (Sections 21001-21007)
- Extended clean energy production credit with a new phase-out date (2032 or when greenhouse gas emissions reach 25% of 2022 levels)
- Extended clean electricity investment credit for wind and solar facilities
- Restored credit for wind and solar leasing arrangements
- Extended clean hydrogen production credit (construction date reverted to 2033)
- Extended residential clean energy credit (termination date moved to 2034)
- Reinstated special rate for sustainable aviation fuel (35 cents/ gallon for certain facilities)
## Energy Efficiency Credits (Sections 22001-22004)
- Restored product identification number requirement for energy-efficient home improvements
- Extended new energy efficient home credit (acquisition date moved to 2032)
- Repealed termination of new energy efficient commercial buildings deduction
- Restored cost recovery for energy property
## Electric Vehicle and Charging Infrastructure Credits (Sections 23001-23005)
- Extended previously-owned vehicle credit (acquisition date moved to 2032)
- Extended clean vehicle credit (placement in service date moved to 2032)
- Extended commercial clean vehicles credit (termination date moved to 2032)
- Extended alternative fuel vehicle refueling property credit (termination date moved to 2032)
- Created a new credit for electric bicycles (30% of cost, up to $5,000 per bicycle)
## Clean Infrastructure and Resiliency Credits (Sections 24001-24007)
- Created qualifying water reuse project credit (30% of qualified investment)
- Created recycling property investment credit (30% of qualified investment with phase-out)
- Excluded amounts received from State-based catastrophe loss mitigation programs from gross income
- Expanded exclusion for certain emergency agricultural assistance
- Created credit for disaster mitigation expenditures (30% of qualifying mitigation activities)
- Created qualifying electric power transmission line credit (30% of qualified investment)
- Created qualifying advanced battery project credit (30% of qualified investment with $3 billion cap)
The proposed amendments generally extend existing credits through 2032-2037, with some credits having phase-out schedules and others having specific termination dates. The document also includes numerous conforming amendments to other sections of the tax code to accommodate these changes.
The Antisemitism Response and Prevention Act of 2025 aims to combat rising antisemitism through evidence-based policies rather than political weaponization. It requires universities to designate Title VI coordinators to handle civil rights complaints, establishes a National Coordinator to Counter Antisemitism within the Department of Justice, and creates a Hate Crime Reporting Center at the FBI to improve data collection on hate crimes. The bill prohibits using antisemitism accusations to restrict diversity programs, political advocacy, or immigration policies, and ensures nonprofit security grants for Jewish community centers cannot be tied to unrelated political conditions. The legislation authorizes $280 million annually for the Department of Education's Office for Civil Rights and $50 million for the Hate Crime Reporting Center from 2027-2032.
The SPEED Act reforms the National Environmental Policy Act (NEPA) to streamline federal environmental reviews for projects. It limits agencies to considering only "proximate" environmental effects directly tied to a specific project (not speculative or distant impacts), sets strict 180-day deadlines for court remands, and restricts judicial review to procedural errors - not environmental outcomes. This primarily affects federal agencies (like the EPA or Corps of Engineers) and project developers (e.g., for infrastructure, energy, or construction projects) by reducing review scope and accelerating approvals. The bill clarifies NEPA is purely procedural, prohibiting courts from substituting their judgment on environmental effects or delaying actions for new scientific data after deadlines.
This bill allows state veterans homes certified by the Department of Veterans Affairs (VA) to be automatically deemed compliant with Medicare’s nursing home standards, eliminating redundant inspections. It requires the VA to provide documentation of inspections, undergo biennial joint reviews with Medicare officials to confirm alignment, and maintain the same care and safety standards as Medicare requires. The bill also mandates that VA inspection data for these homes be publicly reported on the Nursing Home Care Compare website. This applies to all state veterans homes meeting the defined standards, effective 90 days after enactment.
This bill corrects retirement benefits for specific U.S. Customs and Border Protection (CBP) officers hired between 2008. It applies to officers who received a job offer before July 6, 2008, but started work on or after that date. The bill ensures these officers receive the minimum retirement benefit amount required by law and are exempt from mandatory retirement age rules. It also requires retroactive payments to officers who retired before the law’s enactment.
FDA Modernization Act 3.0 This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug. The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications, and may make other changes to the regulations as appropriate. The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule.
